|
|
||||||||
The Annals of Thoracic Surgery, Vol 47, 539-544, Copyright © 1989 by The Society of Thoracic Surgeons
TR Walsh, J Guttendorf, S Dummer, RL Hardesty, JM Armitage, RL Kormos and BP Griffith
The impact of protective isolation on the incidence of infection in 60
cardiac transplant recipients (mean age, 49.2 years) was studied in a
prospective randomized trial. Thirty patients were randomized to protective
isolation, which consisted of private room, hat, mask, sterile gown, and
handwashing. Thirty patients were randomized to no isolation, which meant
they recovered in a crowded, open intensive care unit and were adjacent to
recipients of liver transplants or patients who were on the trauma,
neurosurgical, and general surgical services, many of whom had an infection
of the incision or a pulmonary infection. There was no difference between
groups in the proportion of patients in whom infection developed (chi 2[1]
= 0.27; p = 0.6), the number of infection-related deaths (2 in each group),
the types of infection (bacterial, viral, fungal, or protozoal), or the
overall outcome. Because protective isolation offered no benefit over
standard care in protecting these patients from infections or the
associated complications, we have discontinued its routine use after
cardiac transplantation.
ARTICLES
The value of protective isolation procedures in cardiac allograft recipients
Department of Surgery, University of Pittsburgh, Pennsylvania.
This article has been cited by other articles:
![]() |
B. T. Bethea, D. D. Yuh, J. V. Conte, and W. A. Baumgartner Heart Transplantation Card. Surg. Adult, January 1, 2003; 2(2003): 1427 - 1460. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |